TABLE 2.
|
|
|
||||
---|---|---|---|---|---|---|
Biochemical recurrence at 5 years
|
Metastatic progression at 10 years
|
Death from any cause at 10 years
|
||||
Odds Ratio (± 95% CI) | P value | Odds Ratio (± 95% CI) | P value | Odds Ratio (± 95% CI) | P value | |
| ||||||
SChLAP1 (high vs. low) | 1·76 (1·28 – 2·41) | 0·00044 | 2·45 (1·70 – 3·53) | <0·0001 | 1·93 (1·31 – 2·85) | 0·00096 |
Gleason score | 1·56 (1·33 – 1·82) | <0·0001 | 2·14 (1·77 – 2·58) | <0·0001 | 2·06 (1·69 – 2·51) | <0·0001 |
PSA | 1·01 (0·99 – 1·02) | 0·061 | 1·01 (0·99 – 1·02) | 0·26 | 1·00 (0·99 – 1·01) | 0·89 |
Seminal vesicle invasion | 1·76 (1·25 – 2·49) | 0·0013 | 1·44 (0·96 – 2·16) | 0·074 | 1·79 (1·16 – 2·75) | 0·0083 |
Surgical margin status | 1·38 (1·03 – 1·86) | 0·030 | Not included | 1·28 (0·87 – 1·89) | 0·21 | |
Extracapsular extension | 1·20 (0·87 – 1·63) | 0·27 | 1·08 (0·74 – 1·58) | 0·69 | 1·05 (0·69 – 1·61) | 0·81 |
Lymph node invasion | Not included | 1·14 (0·65 – 2·01) | 0·64 | 1·31 (0·74 – 2·32) | 0·35 |